Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Kataoka, Y. [1 ]
Hirano, K. [1 ]
Narabayashi, T. [2 ]
Hara, S. [3 ]
Fujimoto, D. [4 ]
Tanaka, T. [5 ]
Ebi, N. [6 ]
Tomii, K. [4 ]
Yoshioka, H. [5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[2] Jcho Osaka Hosp, Osaka, Japan
[3] Itami City Hosp, Dept Internal Med, Itami, Hyogo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[5] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[6] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
immunotherapy; NSCLC; biomarker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-004
引用
收藏
页码：S1995 / S1995
页数：1
相关论文
共 50 条
  • [41] Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis
    Kobayashi, Keigo
    Nakachi, Ichiro
    Naoki, Katsuhiko
    Satomi, Ryosuke
    Nakamura, Morio
    Inoue, Takashi
    Tateno, Hiroki
    Sakamaki, Fumio
    Sayama, Koichi
    Terashima, Takeshi
    Koh, Hidefumi
    Abe, Takayuki
    Nishino, Makoto
    Arai, Daisuke
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Soejima, Kenzo
    Betsuyaku, Tomoko
    CLINICAL LUNG CANCER, 2018, 19 (03) : E349 - E358
  • [42] Molecular profiles of predictive biomarkers for platinum-based chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Seyedabadi, NiloofarTaleghani
    Shoushtari, Sara YousefZadeh
    Soofi, Asma
    Arabpour, Javad
    Shams, Zinat
    Akhavan, Homa
    Hosseini-Asl, Saied
    META GENE, 2022, 31
  • [43] Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer
    Nie, Xiaoqun
    Xia, Liliang
    Gao, Fang
    Liu, Lixia
    Yang, Yi
    Chen, Yingying
    Duan, Huangqi
    Yao, Yaxian
    Chen, Zhiwei
    Lu, Shun
    Wang, Ying
    Yang, Chen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [44] Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Multicenter Retrospective Study
    Wang, S.
    Xing, P.
    Ma, D.
    Wang, Q.
    Hao, X.
    Wang, M.
    Wang, Y.
    Shan, L.
    Xin, T.
    Liang, L.
    Liang, H.
    Du, Y.
    Zhang, Z.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S905 - S906
  • [45] Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study
    Bersanelli, Melissa
    Buti, Sebastiano
    Giannarelli, Diana
    Leonetti, Alessandro
    Cortellini, Alessio
    Lo Russo, Giuseppe
    Signorelli, Diego
    Toschi, Luca
    Milella, Michele
    Pilotto, Sara
    Bria, Emilio
    Proto, Claudia
    Marinello, Arianna
    Randon, Giovanni
    Rossi, Sabrina
    Vita, Emanuele
    Sartori, Giulia
    D'Argento, Ettore
    Qako, Eva
    Giaiacopi, Elisa
    Ghilardi, Laura
    Bettini, Anna Cecilia
    Rapacchi, Elena
    Mazzoni, Francesca
    Lavacchi, Daniele
    Scotti, Vieri
    Ciccone, Lucia Pia
    De Tursi, Michele
    Di Marino, Pietro
    Santini, Daniele
    Russano, Marco
    Bordi, Paola
    Di Maio, Massimo
    Audisio, Marco
    Filetti, Marco
    Giusti, Raffaele
    Berardi, Rossana
    Fiordoliva, Ilaria
    Cerea, Giulio
    Pizzutilo, Elio Gregory
    Bearz, Alessandra
    De Carlo, Elisa
    Cecere, Fabiana
    Renna, Davide
    Camisa, Roberta
    Caruso, Giuseppe
    Ficorella, Corrado
    Banna, Giuseppe Luigi
    Cortinovis, Diego
    Brighenti, Matteo
    LUNG CANCER, 2020, 150 : 123 - 131
  • [46] The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study
    Cao, Qiang
    Wu, Xinyan
    Chen, Yuquan
    Wei, Qi
    You, Yanwei
    Qiang, Yi
    Cao, Guangzhu
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [47] A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Jiang, Zedong
    Zhou, Yao
    Huang, Juan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Predictive Biomarker Testing for Programmed Cell Death 1 Inhibition in Non-Small Cell Lung Cancer
    Sheffield, Brandon S.
    Geller, Georgia
    Pleasance, Erin
    Zachara-Szczakowski, Susanna
    Milne, Katy
    Kalloger, Steve E.
    Zhao, Eric
    Bidnur, Samir
    Jones, Martin
    Nelson, Brad H.
    Yip, Stephen
    Marra, Marco A.
    Laskin, Janessa
    Ho, Cheryl
    Ionescu, Diana
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
  • [49] Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Alfranca, Yolanda Lage
    Garcia, Maria Eugenia Olmedo
    Rueda, Ana Gomez
    Ballesteros, Pablo Alvarez
    Rodriguez, Diana Rosero
    Velasco, Marisa Torres
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [50] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
12345